US Stock MarketDetailed Quotes

BNTC Benitec Biopharma

Watchlist

9.4900
+0.0200+0.21%

Close May 17 16:00 ET

9.0800
-0.4100-4.32%

Post 19:30 ET

88.90MMarket Cap-988P/E (TTM)

Benitec Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Mar 31, 2024

(Q2)Dec 31, 2023

(Q1)Sep 30, 2023

(FY)Jun 30, 2023

(Q4)Jun 30, 2023

(Q3)Mar 31, 2023

(Q2)Dec 31, 2022

(Q1)Sep 30, 2022

(FY)Jun 30, 2022

(Q4)Jun 30, 2022

Total revenue

2.74%75K

12.50%54K

-44.00%14K

23.73%73K

Operating revenue

--0

2.74%75K

--7K

12.50%54K

-44.00%14K

--0

23.73%73K

--0

Cost of revenue

Gross profit

Operating expense

-5.78%4.14M

23.17%6.93M

28.25%5.87M

6.86%19.16M

-3.82%4.56M

25.29%4.4M

15.72%5.62M

-5.02%4.58M

31.29%17.93M

22.84%4.74M

Selling and administrative expenses

28.50%1.58M

-2.09%1.82M

-19.22%1.55M

-3.97%6.38M

-11.72%1.37M

-8.15%1.23M

8.69%1.86M

-5.97%1.92M

2.06%6.65M

1.11%1.55M

-General and administrative expense

28.50%1.58M

-2.09%1.82M

-19.22%1.55M

-3.97%6.38M

-11.72%1.37M

-8.15%1.23M

8.69%1.86M

-5.97%1.92M

2.06%6.65M

1.11%1.55M

Research and development costs

-18.98%2.57M

35.66%5.1M

66.50%4.43M

13.33%12.77M

0.31%3.19M

45.88%3.17M

19.55%3.76M

-4.32%2.66M

60.57%11.27M

36.90%3.18M

Other operating expenses

---3K

--1K

---106K

----

-92.68%9K

----

Operating profit

4.61%-4.14M

-23.48%-6.93M

-28.25%-5.87M

-6.87%-19.08M

3.97%-4.55M

-25.46%-4.34M

-16.03%-5.61M

5.02%-4.58M

-31.32%-17.85M

-22.91%-4.74M

Net non-operating interest income expense

42.86%-4K

33.33%-6K

-3.13%-33K

20.00%-8K

30.00%-7K

18.18%-9K

-800.00%-9K

-433.33%-32K

-900.00%-10K

Non-operating interest expense

-42.86%4K

-33.33%6K

3.13%33K

-20.00%8K

-30.00%7K

-18.18%9K

800.00%9K

433.33%32K

900.00%10K

Other net income (expense)

-173.47%-134K

-35.10%135K

85.32%-74K

-39.13%-448K

67.71%-103K

-125.13%-49K

732.00%208K

-127.03%-504K

-15.00%-322K

-117.01%-319K

Gain on sale of security

-140.82%-118K

-4.43%151K

88.89%-56K

-72.02%-418K

91.45%-23K

-121.88%-49K

532.00%158K

-127.03%-504K

23.34%-243K

-82.99%-269K

Other non- operating income (expenses)

---16K

-132.00%-16K

---18K

62.03%-30K

-60.00%-80K

----

--50K

----

-313.51%-79K

---50K

Income before tax

2.68%-4.28M

-25.63%-6.8M

-16.91%-5.95M

-7.44%-19.56M

8.01%-4.66M

-34.26%-4.4M

-12.24%-5.41M

-0.95%-5.09M

-31.16%-18.21M

-26.58%-5.07M

Income tax

Net income

2.68%-4.28M

-25.63%-6.8M

-16.91%-5.95M

-7.44%-19.56M

8.01%-4.66M

-34.26%-4.4M

-12.24%-5.41M

-0.95%-5.09M

-31.16%-18.21M

-26.58%-5.07M

Net income continuous Operations

2.68%-4.28M

-25.63%-6.8M

-16.91%-5.95M

-7.44%-19.56M

8.01%-4.66M

-34.26%-4.4M

-12.24%-5.41M

-0.95%-5.09M

-31.16%-18.21M

-26.58%-5.07M

Minority interest income

Net income attributable to the parent company

2.68%-4.28M

-25.63%-6.8M

-16.91%-5.95M

-7.44%-19.56M

8.01%-4.66M

-34.26%-4.4M

-12.24%-5.41M

-0.95%-5.09M

-31.16%-18.21M

-26.58%-5.07M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

2.68%-4.28M

-25.63%-6.8M

-16.91%-5.95M

-7.44%-19.56M

8.01%-4.66M

-34.26%-4.4M

-12.24%-5.41M

-0.95%-5.09M

-31.16%-18.21M

-26.58%-5.07M

Basic earnings per share

38.58%-1.64

20.96%-2.64

65.41%-2.76

62.72%-240.04

73.14%-2.8318

60.74%-2.67

66.70%-3.34

24.29%-7.98

-1,072.76%-643.96

-26.58%-10.5412

Diluted earnings per share

38.58%-1.64

20.96%-2.64

65.41%-2.76

62.72%-240.04

73.14%-2.8318

60.74%-2.67

66.70%-3.34

24.29%-7.98

-1,072.76%-643.96

-26.58%-10.5412

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q3)Mar 31, 2024	(Q2)Dec 31, 2023	(Q1)Sep 30, 2023	(FY)Jun 30, 2023	(Q4)Jun 30, 2023	(Q3)Mar 31, 2023	(Q2)Dec 31, 2022	(Q1)Sep 30, 2022	(FY)Jun 30, 2022	(Q4)Jun 30, 2022
Total revenue	0	0	0	2.74%75K	7K	12.50%54K	-44.00%14K	0	23.73%73K	0
Operating revenue	--0	--0	--0	2.74%75K	--7K	12.50%54K	-44.00%14K	--0	23.73%73K	--0
Cost of revenue
Gross profit
Operating expense	-5.78%4.14M	23.17%6.93M	28.25%5.87M	6.86%19.16M	-3.82%4.56M	25.29%4.4M	15.72%5.62M	-5.02%4.58M	31.29%17.93M	22.84%4.74M
Selling and administrative expenses	28.50%1.58M	-2.09%1.82M	-19.22%1.55M	-3.97%6.38M	-11.72%1.37M	-8.15%1.23M	8.69%1.86M	-5.97%1.92M	2.06%6.65M	1.11%1.55M
-General and administrative expense	28.50%1.58M	-2.09%1.82M	-19.22%1.55M	-3.97%6.38M	-11.72%1.37M	-8.15%1.23M	8.69%1.86M	-5.97%1.92M	2.06%6.65M	1.11%1.55M
Research and development costs	-18.98%2.57M	35.66%5.1M	66.50%4.43M	13.33%12.77M	0.31%3.19M	45.88%3.17M	19.55%3.76M	-4.32%2.66M	60.57%11.27M	36.90%3.18M
Other operating expenses	---3K	--1K	---106K	----	----	----	----	----	-92.68%9K	----
Operating profit	4.61%-4.14M	-23.48%-6.93M	-28.25%-5.87M	-6.87%-19.08M	3.97%-4.55M	-25.46%-4.34M	-16.03%-5.61M	5.02%-4.58M	-31.32%-17.85M	-22.91%-4.74M
Net non-operating interest income expense	42.86%-4K	33.33%-6K	33.33%-6K	-3.13%-33K	20.00%-8K	30.00%-7K	18.18%-9K	-800.00%-9K	-433.33%-32K	-900.00%-10K
Non-operating interest expense	-42.86%4K	-33.33%6K	-33.33%6K	3.13%33K	-20.00%8K	-30.00%7K	-18.18%9K	800.00%9K	433.33%32K	900.00%10K
Other net income (expense)	-173.47%-134K	-35.10%135K	85.32%-74K	-39.13%-448K	67.71%-103K	-125.13%-49K	732.00%208K	-127.03%-504K	-15.00%-322K	-117.01%-319K
Gain on sale of security	-140.82%-118K	-4.43%151K	88.89%-56K	-72.02%-418K	91.45%-23K	-121.88%-49K	532.00%158K	-127.03%-504K	23.34%-243K	-82.99%-269K
Other non- operating income (expenses)	---16K	-132.00%-16K	---18K	62.03%-30K	-60.00%-80K	----	--50K	----	-313.51%-79K	---50K
Income before tax	2.68%-4.28M	-25.63%-6.8M	-16.91%-5.95M	-7.44%-19.56M	8.01%-4.66M	-34.26%-4.4M	-12.24%-5.41M	-0.95%-5.09M	-31.16%-18.21M	-26.58%-5.07M
Income tax
Net income	2.68%-4.28M	-25.63%-6.8M	-16.91%-5.95M	-7.44%-19.56M	8.01%-4.66M	-34.26%-4.4M	-12.24%-5.41M	-0.95%-5.09M	-31.16%-18.21M	-26.58%-5.07M
Net income continuous Operations	2.68%-4.28M	-25.63%-6.8M	-16.91%-5.95M	-7.44%-19.56M	8.01%-4.66M	-34.26%-4.4M	-12.24%-5.41M	-0.95%-5.09M	-31.16%-18.21M	-26.58%-5.07M
Minority interest income
Net income attributable to the parent company	2.68%-4.28M	-25.63%-6.8M	-16.91%-5.95M	-7.44%-19.56M	8.01%-4.66M	-34.26%-4.4M	-12.24%-5.41M	-0.95%-5.09M	-31.16%-18.21M	-26.58%-5.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	2.68%-4.28M	-25.63%-6.8M	-16.91%-5.95M	-7.44%-19.56M	8.01%-4.66M	-34.26%-4.4M	-12.24%-5.41M	-0.95%-5.09M	-31.16%-18.21M	-26.58%-5.07M
Basic earnings per share	38.58%-1.64	20.96%-2.64	65.41%-2.76	62.72%-240.04	73.14%-2.8318	60.74%-2.67	66.70%-3.34	24.29%-7.98	-1,072.76%-643.96	-26.58%-10.5412
Diluted earnings per share	38.58%-1.64	20.96%-2.64	65.41%-2.76	62.72%-240.04	73.14%-2.8318	60.74%-2.67	66.70%-3.34	24.29%-7.98	-1,072.76%-643.96	-26.58%-10.5412
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall